Viewing Study NCT05060705


Ignite Creation Date: 2025-12-25 @ 3:10 AM
Ignite Modification Date: 2026-05-26 @ 5:46 AM
Study NCT ID: NCT05060705
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-04-17
First Post: 2021-09-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: "Efesovir" (FS-1) for COVID-19, Phase 2
Sponsor: Scientific Center for Anti-infectious Drugs, Kazakhstan
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Covid19 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None COVID19 View
None viral pneumonia View
None FS-1 View
None Efesovir View